Both studies demonstrated that high expression of HIF-1α, p53 and cancer stems cell marker were significantly associated with tumor recurrence, poor treatment outcome, and poor overall survival in patients with HNSCC treated with RCHT. Here, HIF1A is linked to neoplasm.